SCHEMBL17507367

SCHEMBL17507367

Brc1cccc2c1oc1nc3ccccc3n12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
LCK P06239 4/20 0.37
TP53 P04637 3/20 0.37
ALDH1A1 P00352 3/20 0.37
TSHR P16473 2/20 0.37
USP2 O75604 1/20 0.37
PKM P14618 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ENPP1 P22413 1/20 0.35
MAPT P10636 4/20 0.34
KDM4E B2RXH2 3/20 0.34
HSD17B10 Q99714 2/20 0.34
CSNK1A1 P48729 1/20 0.34
CLK2 P49760 1/20 0.34
LIMK1 P53667 1/20 0.34
DYRK1A Q13627 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34
DYRK1B Q9Y463 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22037061 0.82 RAB9A (0.41) NPC1RAB9ATP53ALDH1A1TSHR
SCHEMBL20041634 0.81 TSHR (0.41) NPC1RAB9ALCKTP53ALDH1A1
SCHEMBL17507333 0.78 HPGD (0.42) NPC1RAB9ATP53ALDH1A1PKM
SCHEMBL17507336 0.76 HPGD (0.40) NPC1RAB9ATP53ALDH1A1PKM
SCHEMBL17507255 0.75 RAB9A (0.48) NPC1RAB9ATP53ALDH1A1TSHR
SCHEMBL17491667 0.75 NPC1 (0.48) NPC1RAB9ATP53ALDH1A1TSHR
SCHEMBL17491659 0.74 NPC1 (0.66) NPC1RAB9ATP53ALDH1A1TSHR
SCHEMBL22100073 0.74 KDM4E (0.38) NPC1RAB9ATP53ALDH1A1TSHR
SCHEMBL17507335 0.74 HPGD (0.39) NPC1RAB9ATP53ALDH1A1PKM
SCHEMBL17507371 0.74 KDM4E (0.40) NPC1RAB9ATP53ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10944062-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2021-03-09 US disclosed
US-20180337351-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-11-22 US disclosed
EP-2982676-B1 Benzimidazo[2,1-B]benzoxazoles for electronic applications IDEMITSU KOSAN CO (JP) 2018-04-11 EP disclosed
EP-2982676-A1 Benzimidazo[2,1-B]benzoxazoles for electronic applications Idemitsu Kosan Co., Ltd. (JP) 2016-02-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10944062-B2 Organic electroluminescent materials and devices NDUFS2, ETFA, NDUFS3 NPC1 4047/4885RAB9A 3337/4885LCK 599/4885
US-20180337351-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES NDUFS2, ETFA, NDUFS3 NPC1 4047/4885RAB9A 3337/4885LCK 599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.